Objective: The objective of this study was to evaluate the performance of the Amedica -TL fusion device in two patients with a history of posterior lumbar interbody spinal fusion.
Historically, reports of transforaminal lumbar interbody fusion (TLIF), first described by Blume [2] and popularized by Harms and Rolinger [3] , reflect good clinical and radiographic outcomes [4] [5] [6] [7] [8] . In the TLIF procedure, a structural support (allograft bone or assorted cage designs) is placed within the middle or anterior aspect of the disc space via a posterolateral transforaminal route accompanied by pedicle screw fixation [5, 8, 9] . Many interbody grafts have been created that not only focus on restoring disc height but also maintain lordosis through the vertebral segment, create distraction and restore the normal weight distribution within the anterior column [8] .
Considering the advantageous features of the TLIF technique, the design of the synthetic interbody graft chosen for the procedure may potentially affect the radiographic success of the procedure.
Originally, titanium cages were placed in the interbody space during a TLIF procedure [5] . These cages lead to subsidence through the vertebral body endplates, especially in osteoporotic patients, because the modulus of elasticity for titanium is much greater than bone [5] . Postoperative imaging was also challenging with the titanium interbody implants as the titanium results in significant image distortion making fusion determination challenging. With the problems associated with the use of metal cages, nonresorbable polymers, such as PEEK or carbon fiber reinforced PEEK (CFRP), were developed since these polymers exhibited similar mechanical properties to that of bone [5, 10] . Yet, a large case series found that the rates of collapse, slippage and graft migration associated with the use of CFRP and PEEK cages were found to occur at rates of 3-10% [5, 11] . Therefore, there was a clear need to identify a better material for spinal fusions.
The Valeo
® (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT) ceramic implant is composed of micro-composite ceramic with a surface that mimics cancellous structure. Valeo ® is advertised to mimic the structure of bone by incorporating both a dense load-bearing component (fracture resistant) and a porous component, coupled with a surface texture, to promote bone attachment, more than traditional metal implants such as PEEK and titanium. Along with the increased bone growth properties (growth onto the implant as well as through the implant), and due to its composition the graft should also have better compatibility with surgical and diagnostic imaging techniques, which is vital for intraoperative placement of the graft. However, at this time, there is a lack of published data on the performance of the Valeo
Introduction
When non operative actions for degenerative spinal disorders fall flat, surgical intervention frequently becomes the popular choice of treatment. Although the class of pathology matters, the surgical operation will generally include an arthrodesis procedure. The gravity of a successful initial fusion surgery is intensified not only by the growing number of arthrodesis procedures, but also by the rising costs for revisal operations. Additionally, fusion success appears to have an impact on patient reported outcomes [1] .
A B This case study reviews the performance of the Amedica -TL fusion device in posterior transforaminal interbody spinal fusion by describing the clinical and radiographic outcomes of two patients with one year follow up.
Case report 1 History and physical examination
A 47-year-old, non-osteoporotic woman reported back pain and weakness in her legs. The patient was diagnosed with lumbar spinal stenosis at L4-L5 with neurogenic claudication and axial low back pain at L4-L5. A neurological deficit was noted at her extensor hallucis longus bilaterally (4+/5).
Preoperative radiographic imaging
The MRI showed progressive disc herniation at L4-L5, moderate lateral recess stenosis, severe facet arthropathy, and Modic type 2 changes within the vertebral bodies of L4 and L5 ( Figure 1a 
Preoperative management
The patient was treated conservatively with physical therapy and oral medications. Due to the lack of improvement, treatment proceeded with diagnostic and therapeutic bilateral L5 transforaminal epidural injections. The injections were repeated in 2 months with no resolution of pain. As a result, surgery was recommended.
Operative management
A standard decompression, including laminectomy and facetectomy, and posterior spinal fusion (PSF) with instrumentation and TLIF with application of a Valeo ® (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT) ceramic implant was performed. Bone morphogenetic protein (Medtronic INFUSE ® Bone Graft, Minneapolis, MN) was placed in the ceramic implant. Bone marrow aspirate, allograft, and local autograft harvested from lamina and spinous processes were placed posterior to the implant and in the disc space. postoperatively, all preoperative symptoms were resolved, and no neurological deficits were present, and the patient was walking over two miles a day. At eight-weeks postoperatively, the patient was enrolled into six weeks of physical therapy, and continued to do well clinically.
Postoperative course
At one-year follow-up, bone appeared to be molded to the Valeo ® implant (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT), as well as through and behind the implant in the interbody zone. The patient demonstrated an anterior grade I fusion, and a posterior grade II fusion via x-rays [12] (Figure 4 ). The CT also displayed fusion based on Brantigan's et al. [13] definition; that is, "the level was regarded as fused as there was radiographic evidence of bone bridging the disc space with no lucency" ( Figure  5 ). Subsidence was deemed a grade zero [14] . Post-operative imaging was not distorted by the interbody implant, thus making fusion and subsidence assessments predictable.
Case Report 2 History and physical examination
A 77-year-old, non-osteoporotic female described low back pain and bilateral leg pain, left greater than right. The patient was diagnosed with lumbar spinal stenosis L4-L5 and disc space collapse L4-L5. She had no neurological deficits preoperatively.
Preoperative radiographic imaging
A sagittal MRI scan showed L4-5 disc dissecation (Figure 6a ). An axial MRI image of L4-5 demonstrated foraminal stenosis, most severe on the right at L4-L5 with disc bulging, disc osteophyte complex, asymmetric disc collapse and severe stenosis on the right (Figure 6b) . AP, lateral and flexion-extension x-rays showed degenerative disk disease at L4-5 without signs of instability ( Figure  7(a & d) , respectively).
Preoperative management
The patient was treated conservatively with physical therapy and oral medications. Due to the lack of improvement, treatment proceeded with diagnostic and therapeutic bilateral L5 transforaminal epidural injection. The patient failed non-operative efforts and was offered operative intervention.
Operative management
Similar to the first case report, the patient underwent a standard decompression (laminectomy and facetectomy), PSF with instrumentation and TLIF with application of a Valeo ® (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT) ceramic implant. Bone morphogenetic protein (Medtronic INFUSE ® Bone Graft, Minneapolis, MN) was placed in the ceramic implant. Bone marrow aspirate, allograft and local autograft harvested from the lamina and spinous processes were placed posterior to the implant and in the disc space.
Postoperative course
Length of stay was two days in the hospital without complications. At two weeks postoperatively, the patient had some mild left leg pain, which decreased gradually. However, no neurological deficits were noted. The patient was treated with a brace for eight weeks postoperatively and started physical therapy shortly after being weaned off the brace. Postoperative x-rays demonstrated excellent placement of the implants, and no hardware loosening, failure or graft extrusion (Figure 8 ).
At 14 months, like case 1, bone seemed to be effectively formed to the Valeo ® implant (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT), as well as through and dorsal to the cage in the interbody space. Per x-rays, the patient demonstrated grade I fusions both anteriorly and posteriorly [12] (Figure 9 ). Also comparable to case 1, the CT displayed fusion success "as there was radiographic evidence of bone bridging the disc space with no lucency" [13] (Figure 10 ). Subsidence was judged to be a grade zero [14] . There was no distortion of the imaging due to the implant.
Discussion
The present case study aimed to assess the efficacy of the Amedica -TL fusion device in two patients with a history of posterior interbody spinal fusion. We found that the Valeo ® (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT) ceramic implant demonstrated solid bony growth on both the implant and through the implant in both patients on dynamic x-rays and CT scans at 1-year follow up. The post-operative imaging was not distorted by the interbody implant, making fusion assessment predictable, and there was no evidence of subsidence.
Most ceramics are attributed with osteointegration and osteoconductive properties. However, they do lack osteoinductive properties that are associated with allograft or autograft bone [15, 16] . The ceramic grafts are dependent on the remaining bone for their successful outcome [16] . Researchers have tried to provide this capacity to ceramic implants by adding bone marrow cells [17] in addition to osteoinductive proteins [15] to improve their osteoinductive capabilities. Both patients received BMP and bone marrow aspirate, which could help explain the solid bony fusion, but there is not enough consistent evidence. Future, high-quality studies will need to test this theory.
The lack of subsidence, migration and implant fracture/failure was expected due to the potential theoretical advantages of the the Valeo ® (Valeo ® TL VBR Lumbar Spacer, Amedica Corporation, Salt Lake City, UT) ceramic implant, and that neither patient had osteoporosis. No subsidence and no change in implant placement is clinically relevant as it importantly preserves the desired maintenance of the interbody disc space restoration and sagittal alignment. Unlike titanium, PEEK and CFRP cages, which have been known to subside [5] , slip and migrate [5, 11] , as there is no ability for bony ingrowth to the native vertebral bodies [4, 18, 19] , ceramics are thought to be safe, and believed to be associated with a high bone-bonding capacity. The proprietary nature of the ceramic, composed of medical grade silicon nitride with a special textured cortico-cancellous structured surface, has been suggested to allow bony ingrowth to occur to the corresponding vertebral bodies. Additionally, the ceramic implant has been marketed as a dense, hydrophilic construct for load bearing that is strong and can exhibit high fracture toughness. The concern has lied in the fact that few peer-reviewed publications have been available to confirm these theories. In the present case report, the patients demonstrated bone ingrowth to the implant was able to occur at the same rate as the interbody fusion, which is likely why the implant did not subside or migrate in either patient.
Since the interbody spacer is one of the key players of a successful fusion, our results suggest that a ceramic implant may be a better option in a TLIF procedure than other standardly used implants made out of titanium, PEEK or CFRP. Future prospective, comparative studies with large sample sizes will need to confirm the present results and anecdotal theories.
Historically, sophisticated imaging was challenging with a titanium interbody implant as the titanium results in significant image distortion due to metallic scatter and distortion, which made intra op placement and fusion determination challenging. An abstract presented at the 8 th Annual Spine Arthroplasty Society Global Symposium on Motion Preservation Technology compared the clinical visibility of cylindrical shaped specimens composed of cobalt chromium, polyetherketone (PEEK), titanium and silicon nitride ceramic [20] . As compared to the other commercially available specimens, the study concluded that silicon nitride ceramic implants may be easier to follow postoperatively due to lack of distortion under magnetic resonance and lack of scattering under computed tomography.
Two major limitations of this paper are obvious. First, this was a case study paper; thus, only two non-osteoporotic patients were reviewed. Second, there were no comparative counterparts for these two patients. Nonetheless, these cases are unique and will aid future work.
Conclusion
Both patients demonstrated solid bony fusion on dynamic x-rays and CT scans at 1-year follow up, which may be due to the unique ceramic qualities and better imaging compatibility of the Valeo ® ceramic implant. In addition, in these two non-osteoporotic patients, there was no evidence of subsidence, migration or implant fracture/ failure. Our findings suggest that the ceramic implant may provide an attractive alternative for use in a TLIF procedure as compared to standard titanium, PEEK or CFRP implants. The need for a larger prospective study to determine the efficacy of the use of Valeo ® is warranted.
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